Necloral (Cefaclor)

Cefaclor belongs to the β‑lactam class and works by binding to penicillin‑binding proteins on bacterial cell walls. This inhibits the cross‑linking of peptidoglycan strands, weakening the wall and causing bacterial lysis. The mechanism is bactericidal and targets susceptible respiratory pathogens.

The exact dose of Necloral is set by a qualified prescriber based on the patient’s age, weight, severity of infection, and renal function. Dosage regimens are individualized and should follow the prescribing information provided by the healthcare professional.

Cefaclor’s pregnancy category is listed as unknown, and safety data are limited. The drug should only be used during pregnancy or lactation if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the treating physician.

To request Necloral, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Cefaclor is a second‑generation cephalosporin, offering broader activity against certain Gram‑negative organisms compared with amoxicillin, a penicillin‑type drug. Both are β‑lactam antibiotics, but cefaclor may be preferred when resistance to amoxicillin is suspected or when a patient tolerates cephalosporins better.

Necloral tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Keep the product away from moisture and direct sunlight to maintain stability throughout its shelf life.

Necloral is taken orally with a full glass of water. It can be taken with or without food, but consistent administration with respect to meals helps maintain stable drug levels. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

The most serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare dermatologic events like Stevens‑Johnson syndrome. Prompt medical attention is required if signs of these reactions appear, such as difficulty breathing, severe rash, or persistent diarrhea.

Necloral should not be used by individuals with a known hypersensitivity to cefaclor, other cephalosporins, or any β‑lactam antibiotics. Patients with severe renal impairment may require dose adjustment or alternative therapy, and those with a history of severe drug‑induced skin reactions should avoid its use.